Compare MF & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MF | NXL |
|---|---|---|
| Founded | N/A | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5M | 10.6M |
| IPO Year | 2021 | 2022 |
| Metric | MF | NXL |
|---|---|---|
| Price | $13.00 | $0.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 219.7K | 167.8K |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $301,647.00 |
| Revenue This Year | N/A | $15.52 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 78.78 |
| 52 Week Low | $5.07 | $0.31 |
| 52 Week High | $11.75 | $2.00 |
| Indicator | MF | NXL |
|---|---|---|
| Relative Strength Index (RSI) | 88.46 | 43.97 |
| Support Level | N/A | $0.34 |
| Resistance Level | N/A | $0.49 |
| Average True Range (ATR) | 2.01 | 0.04 |
| MACD | 0.43 | -0.00 |
| Stochastic Oscillator | 67.84 | 33.58 |
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the US and China, with China generating the maximum sales.